Heron: Heron Therapeutics Wins Patent Lawsuit Against Fresenius Kabi For CINVANTI

(RTTNews) - Heron Therapeutics Inc. (HRTX), a commercial-stage biotechnology company, announced on Tuesday that the U.S. District Court for the District of Delaware has ruled in its favor in a patent litigation against Fresenius Kabi regarding CINVANTI injectable emulsion.